Surendralal Lanca Karsanbhai Emerson Electric CO (EMR) insider trading activity

Surendralal Lanca Karsanbhai is CEO and President of EMERSON ELECTRIC CO. Currently has a direct ownership of 181,913 shares of EMR, which is worth approximately $22.2 Million. The most recent transaction as insider was on Dec 17, 2024, when has been sold 12,698 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K

6.52% 3M change

31.11% 12M change

Total Value Held $22.2 Million

Surendralal Lanca Karsanbhai Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 17 2024	SELL Bona fide gift	-	12,698 Reduced 6.52%	181,913 Common Stock
Nov 07 2024	SELL Bona fide gift	-	72,282 Reduced 27.08%	194,611 Common Stock
Nov 06 2024	SELL Payment of exercise price or tax liability	$1,259,166 $125.44 p/Share	10,038 Reduced 3.62%	266,893 Common Stock
Nov 04 2024	SELL Payment of exercise price or tax liability	$6,234,545 $109.11 p/Share	57,140 Reduced 20.96%	215,490 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	190,863 Added 40.8%	276,931 Common Stock
Jun 28 2024	SELL Bona fide gift	-	542 Reduced 0.39%	138,208 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$118,061 $105.98 p/Share	1,114 Reduced 0.78%	141,094 Common Stock
Feb 14 2024	SELL Open market or private sale	$248,510 $106.02 p/Share	2,344 Reduced 1.66%	138,750 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	$251,360 $62.84 p/Share	4,000 Added 2.74%	142,208 Common Stock
Nov 10 2023	SELL Bona fide gift	-	67,655 Reduced 32.86%	138,208 Common Stock
Nov 06 2023	BUY Grant, award, or other acquisition	-	130,863 Added 38.86%	205,863 Common Stock
Dec 01 2022	SELL Bona fide gift	-	1,475 Reduced 1.93%	75,000 Common Stock
Nov 16 2022	SELL Open market or private sale	$441,243 $95.86 p/Share	4,603 Reduced 4.42%	99,591 Common Stock
Nov 16 2022	SELL Payment of exercise price or tax liability	$375,531 $95.75 p/Share	3,922 Reduced 3.91%	96,449 Common Stock
Nov 16 2022	SELL Bona fide gift	-	19,974 Reduced 20.71%	76,475 Common Stock
Nov 16 2022	BUY Exercise of conversion of derivative security	$650,699 $65.07 p/Share	10,000 Added 8.7%	104,974 Common Stock
Oct 31 2022	BUY Grant, award, or other acquisition	-	19,974 Added 17.38%	94,974 Common Stock
Nov 08 2021	SELL Bona fide gift	-	18,609 Reduced 19.88%	75,000 Common Stock
Nov 01 2021	BUY Grant, award, or other acquisition	-	18,609 Added 16.58%	93,609 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	50,000 Added 40.0%	75,000 Common Stock
Dec 01 2020	SELL Bona fide gift	-	7,700 Reduced 23.55%	25,000 Common Stock
Nov 03 2020	BUY Grant, award, or other acquisition	-	12,700 Added 27.97%	32,700 Common Stock

Also insider at

MRK

Merck & Co., Inc. Healthcare

Director

SLK